Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug , the first daily oral medication to .The FDA's approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. ,…
Continue reading...